Experiments in which fluorescently labeled AML cells were inoculated into mice revealed that CD8α+ DCs were uniquely capable of engulfing AML cells in vivo and of cross-presenting AML cell-derived antigens to T cells ex vivo (23). This evidence concerns the gene CD8A and acute myeloid leukemia.